Approximately 100 million Americans report they suffer from some type of chronic pain, costing the US between $560 and $635 billion annually.
The extended-release (ER)/long-acting (LA) opioid analgesics are effective pharmacologic solutions for many chronic pain patients. However, in the United States:
- Misuse or abuse of prescription painkillers resulted in almost 500,000 Emergency Department visits in 2009
- More people die from unintentional overdose deaths involving opiate analgesics than from cocaine and heroin combined
- Drug poisoning is responsible for more deaths than motor vehicle traffic accidents annually
How can clinicians impact an epidemic that is responsible for more deaths in the past four years than the entire Vietnam War?
- By utilizing safe, responsible opioid prescribing
- By conducting appropriate patient assessments and monitoring
- By knowing the law, and knowing how to use best practices with every patient
|Yes! I want to learn how to protect my patients, my practice, and my community! Click here to learn more about this focused, continuing education opportunity.|
The Emerging Solutions in Pain Responsible Opioid Prescribing Initiative is a collection of applied clinical educational activities, tools, and resources developed through a collaborative effort by a consortium of medical and education professionals specializing in pain medicine.
Organizations participating in the ESP Responsible Opioid Prescribing Initiative include:
|The American Academy of Pain Management|
|MediCom Worldwide and Emerging Solutions in Pain (ESP)|
|Dental Learning Systems|
|Primary Care Network|
The Emerging Solutions in Pain Responsible Opioid Prescribing Initiative is a comprehensive educational activity and resource that has been specifically designed to support safe and effective prescribing of ER/LA opioids in clinical practice. Every element of the ESP Responsible Opioid Prescribing Initiative has been developed with the needs of the practicing clinician in mind.
|The ESP Responsible Opioid Prescribing Activity|
This six-module, accredited video series will provide you with knowledge and information that will support safe and effective prescribing of ER/LA opioids in your practice. If you prefer, you can also download and print a transcript and read each module at your convenience. All clinicians who successfully complete this educational activity will receive, in addition to their CE certificate, a Certificate of Compliance from the American Academy of Pain Management attesting to successful completion of a REMS compliance program.
|The ESP Legal/Regulatory Practice Support Resource |
This video-based series addresses six of the most common and challenging questions clinicians encounter as they prescribe ER/LA opioid analgesics. Each video corresponds to one of the six modules in the ESP Responsible Opioid Prescribing Activity, and is presented by one of the country’s leading lawyers specializing in regulations pertaining to prescription of opioid analgesics.
|The ESP How Would I Treat This Patient? Case Series |
This case library represents the most common clinical challenges associated with prescribing ER/LA opioid analgesics for chronic pain. These expert-authored cases will allow you to find cases similar to clinical challenges you’ve encountered in your own practice, and learn how an expert would proceed. Two cases have been developed for each of the six modules in the ESP Responsible Opioid Prescribing Activity.
|The ESP Responsible Opioid Prescribing Practice Support Center |
The Practice Support Center is a collection of validated tools, resources, and patient education pieces that support safe and effective prescribing of ER/LA opioid analgesics.
The ESP Responsible Opioid Prescribing Activity is provided by the American Academy of Pain Management. Collaborating organizations include MediCom Worldwide, Inc., Dental Learning Systems, and the Primary Care Network.
This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see www.er-la-opioidREMS.com for a listing of the member companies.
This activity is intended to be fully compliant with the ER/LA Opioid Analgesic REMS education requirements issued by the US Food & Drug Administration (FDA).